Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...
A systematic review and meta-analysis compared the perioperative and oncologic outcomes of open versus minimally invasive inguinal lymphadenectomy during penile cancer surgery. A meta-analysis ...
ILC makes up 10–15% of all invasive breast cancers but often goes underdiagnosed due to its diffuse growth pattern. The hallmark of ILC is the loss of E-cadherin, leading to its characteristic ...
NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...
In the AXSANA/EUBREAST 3(R) study, researchers compared data about recurrence outcomes of more-invasive and less-invasive lymph node procedures.
Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...
University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...
International Collaboration of Trialists, Medical Research Council Advanced Bladder Cancer Working Party now the National Cancer Research Institute Bladder Cancer Clinical Studies Group, European ...
In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread. MIAMI, FLORIDA / ACCESS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback